Market Access Focus Xcenda specializes in strategic consultancy to enable biopharma partners to communicate and deliver value for market access globally, presenting an opportunity to offer optimization services, payer engagement programs, and evidence generation support to expand access portfolios.

Pharma Ecosystem Partner As part of Cencora/AmerisourceBergen ecosystem with a large global footprint, there is potential to cross-sell through existing distribution, care delivery, and solutions networks to accelerate market access initiatives and bundled services for manufacturers.

Acquisition & Growth Momentum Historically active in acquisitions such as Dymaxium, and leadership changes in 2022, indicating a growth-oriented organization open to integrating new capabilities in evidence exchange, formulary solutions, and payer communications that could complement sales pitches.

Financial Scale Revenue in the mid-range hundreds of millions with a sizable global workforce positions Xcenda as a credible, scalable partner for mid to large biopharma clients seeking outsourced market access, pricing strategy, and health economics services.

Tech & Compliance Readiness Usage of a diverse tech stack including SAP Cloud Platform, SAS, Qualys, and ISO standards signals mature data, analytics, and security capabilities, enabling proposals around data-driven pricing, payer evidence generation, and compliant digital engagement.